JulioPow-SangMD

Urology • Tampa, FL

Professor of Surgery, University S Fla College of Medicine

Join to view full profile

Dr. Pow-Sang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pow-Sang's full profile

Already have an account?

Office
12902 Usf Magnolia Dr
H Lee Moffitt Cancer Ctr, GU Clinic
Tampa, FL 33612
Phone+1 813-745-8418

Fax+1 813-745-4675

Education & Training

University of FloridaResidency, Urology, 1986 - 1987
University of Miami/Jackson Health SystemResidency, Urology, 1983 - 1986
University of Miami/Jackson Health SystemResidency, Surgery, 1981 - 1983
Universidad Autonoma de GuadalajaraClass of 1978

Certifications & Licensure

FL State Medical License 1983 - 2026
American Board of Urology Urology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors: Florida Castle Connolly, 2000

Clinical Trials

Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness Start of enrollment: 2009 Dec 11
Completed
Phase 2
Pilot Study on Focal Prostate Radio-Frequency Ablation Start of enrollment: 2011 Aug 01
Completed
Not Applicable
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA Start of enrollment: 2012 May 01
Terminated
Phase 2
Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma Start of enrollment: 2012 Jul 01
Completed
Phase 1
Navigator Guided e-Psychoeducational Intervention Start of enrollment: 2014 Jun 02
Completed
Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer Start of enrollment: 2016 Jan 27
Completed
Phase 1
Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer Start of enrollment: 2013 Apr 11
Completed
Not Applicable
Clinical Trial of Green Tea Catechins in Men on Active Surveillance Start of enrollment: 2020 Aug 21
Recruiting
Phase 2
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC Start of enrollment: 2020 Oct 26
Active, not recruiting
Phase 1
Non-Invasive Biomarkers in Prostate Cancer Disease Management Start of enrollment: 2023 Nov 21
Recruiting
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

1172 citations
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
James L. Mohler, Emmanuel S. Antonarakis, Andrew J. Armstrong, Anthony V. D'Amico, Brian J. Davis
Journal of the National Comprehensive Cancer Network. 2019-05-01
93 citations
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Daniel Barocas
Journal of the National Comprehensive Cancer Network. 2023-10-01
100 citations
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Daniel Barocas
Journal of the National Comprehensive Cancer Network. 2022-12-01

Lectures

Florida Urological Society 64th Annual Meeting
Florida Urological Society, Orlando, Florida - 8/30/2012

Press Mentions

Digital Rectal Exam Fails as Screening Tool for Prostate CancerMarch 14th, 2023
Some Doctors Debate Name Change for Low-Grade Prostate CancerApril 20th, 2022
Bringing Prostate Cancer Education to High-Burden NeighborhoodsMarch 4th, 2022
Join now to see all